See‐Chun Phan
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Hepatology top 10%
- Liver physiology and pathology
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 4
- HER2/EGFR in Cancer Research 4
-
- Advanced Breast Cancer Therapies 4
- Lung Cancer Treatments and Mutations 4
- Brain Metastases and Treatment 3
- Co-authors
- Stephen P. Hack (5 shared papers)David S. Shames (4 shared papers)Manish A. Shah (2 shared papers)David Cunningham (2 shared papers)Florian Lordick (1 shared paper)Meng Chen (1 shared paper)Yung‐Jue Bang (1 shared paper)Josep Tabernero (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)Blood (2 papers)Clinical Pharmacology & Therapeutics (1 paper)The Oncologist (1 paper)Molecular and Cellular Biology (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
See‐Chun Phan
20 papers receiving 554 citations
See‐Chun Phan's Hit Papers
Peers
Comparison fields: 5 of 47
- Oncology 330
- Hepatology 66
- Pulmonary and Respiratory Medicine 238
- Cancer Research 72
- Gastroenterology 19
Countries citing papers authored by See‐Chun Phan
This map shows the geographic impact of See‐Chun Phan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by See‐Chun Phan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites See‐Chun Phan more than expected).
Fields of papers citing papers by See‐Chun Phan
This network shows the impact of papers produced by See‐Chun Phan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by See‐Chun Phan. The network helps show where See‐Chun Phan may publish in the future.
Co-authors
The 25 scholars most cited alongside See‐Chun Phan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 107 | |
| 2 | Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression Hit paper breakdown → | 2024 | 93 |
| 3 | 2015 | 89 | |
| 4 | 2017 | 49 | |
| 5 | 2018 | 40 | |
| 6 | 2018 | 36 | |
| 7 | 2013 | 30 | |
| 8 | 2015 | 20 | |
| 9 | 2009 | 17 | |
| 10 | 1996 | 13 | |
| 11 | 2017 | 12 | |
| 12 | 2015 | 12 | |
| 13 | 2022 | 12 | |
| 14 | 2005 | 10 | |
| 15 | 2024 | 9 | |
| 16 | 2015 | 6 | |
| 17 | 2022 | 3 | |
| 18 | 2004 | 2 | |
| 19 | 1999 | 2 | |
| 20 | 2005 | 1 |
About See‐Chun Phan
See‐Chun Phan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 21 papers that have together received 564 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), Advanced Breast Cancer Therapies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Retinoids in leukemia and cellular processes (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Brain Metastases and Treatment (3 papers). The work is most often cited by research in Oncology (330 citations), Hepatology (66 citations), Pulmonary and Respiratory Medicine (238 citations), Cancer Research (72 citations) and Gastroenterology (19 citations). See‐Chun Phan has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Stephen P. Hack, David S. Shames, Manish A. Shah, David Cunningham, Florian Lordick, Meng Chen, Yung‐Jue Bang, Josep Tabernero, Jamie E. Chaft and David J. Kwiatkowski. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Pharmacology & Therapeutics, The Oncologist and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.